MDRNA (MRNA) Issued Patent in China for Use of Nucleic Acids to Treat Cancer
Tweet Send to a Friend
MDRNA, Inc. (NASDAQ: MRNA) today announced that the State Intellectual Property Office of the People's Republic of China has issued ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
